Tollip deficiency enhances mitophagy and reduces STING activation in influenza A virus-infected mice

Hamid Reza Nouri1, Niccolette Schaunaman1, Monica Kraft2

  • 1Department of Medicine, National Jewish Health, Denver, CO, United States.

Insights

Toll-interacting protein (Tollip) deficiency worsens viral infection by enhancing mitophagy, which reduces mitochondrial DNA release and STING activation, impairing antiviral responses.

Area of Science:

  • Immunology
  • Cell Biology
  • Virology

Background:

  • Toll-interacting protein (Tollip) regulates mitophagy, a process crucial for cellular health.
  • Tollip deficiency is linked to increased susceptibility to viral infections, but the underlying mechanisms are not fully understood.

Purpose of the Study:

  • To investigate the role of mitophagy, mitochondrial DNA (mtDNA) release, and stimulator of interferon genes (STING) signaling in Tollip-deficient mice infected with influenza A virus (IAV).

Main Methods:

  • Wild-type and Tollip knockout mice were infected with IAV and treated with a STING agonist.
  • PINK1 knockout cells and mice were used to assess the impact of mitophagy.
  • Mitochondrial markers, mtDNA release, STING activation, and antiviral gene expression were analyzed.

Main Results:

  • Tollip deficiency enhanced lung mitophagy and suppressed STING activation and antiviral responses, leading to increased viral load.
  • STING agonist treatment partially restored antiviral responses in Tollip-deficient mice.
  • PINK1 deficiency (impaired mitophagy) increased mtDNA release, augmented STING activation, and enhanced antiviral responses.

Conclusions:

  • Enhanced mitophagy in Tollip deficiency impairs antiviral immunity by reducing mtDNA release and STING activation.
  • Targeting mitophagy or STING signaling may offer therapeutic strategies for viral infections in Tollip-deficient individuals.

Related Concept Videos